Safety and Efficacy of Trifluridine-Tipiracil Hydrochloride Oral Combination (TAS-102) in Patients with Unresectable Colorectal Cancer

Aim: To retrospectively examine efficacy and safety of oral combination of trifluridine and tipiracil hydrochloride (TAS-102) as the second-line therapeutic agent for unresectable colorectal cancer. Patient and Methods: Treatment outcomes of 17 patients who had received TAS-102 at our Institution fr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: NARIHIRO, SATOSHI, SUWA, KATSUHITO, USHIGOME, TAKURO, OHTSU, MASAMICHI, RYU, SYUNJIN, SHIMOYAMA, YUYA, OKAMOTO, TOMOYOSHI, YANAGA, KATSUHIKO
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6365739/
https://ncbi.nlm.nih.gov/pubmed/30348728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11426
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados